ClinicalTrials.Veeva

Menu
Cyn3rgy Research and Development | Gresham, OR logo

Cyn3rgy Research and Development | Gresham, OR

Research site
About
Cyn3rgy Research is a dedicated research site located in Portland, Oregon with over 25 years of clinical trial experience

Site insights

Top conditions

Top treatments

Lisdexamfetamine dimesylate
Lubiprostone
Ruxolitinib
SPD489
CM-AT
Dasotraline
Dexamethasone
Eszopiclone
Ciprofloxacin
SPN-812

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Contact this site

Curt A Heiting, President

Verified by this site

Active trials

13 of 68 total trials

A Clinical Study to Evaluate the Safety, Tolerability, and Immunogenicity of VAX-31 in Healthy Infants

The objective of the study is to evaluate the safety, tolerability, and immunogenicity of 4 injections of VAX-31 (at 4 dose levels) compared to PCV20...

Enrolling
Pneumococcal Vaccines
Biological: 0.5 mL of the mid dose VAX-31
Biological: 0.5 mL of the High-PFS dose VAX-31

The objective of this study is to assess the efficacy and safety of upadacitinib for the treatment of adolescent and adult participants with moderate...

Active, not recruiting
Atopic Dermatitis
Drug: Upadacitinib
Drug: Placebo for Upadacitinib

The purpose of this study is to learn about the safety, tolerability and immune effects of a pneumococcal vaccine in toddlers.Participants will take...

Active, not recruiting
Pneumococcal Disease
Biological: 20-valent pneumococcal conjugate vaccine (20vPnC)
Biological: PG4

The purpose of this study is to learn about the safety of a new pneumococcal vaccine and how the new pneumococcal vaccine helps to fight against germ...

Active, not recruiting
Pneumococcal Disease
Biological: 15-valent pneumococcal conjugate vaccine (PCV15)
Biological: PG4

The purpose of this clinical trial is to learn about the safety, extent of the side effects, and immune responses of the study vaccine (called varian...

Enrolling
COVID-19
SARS-CoV-2 Virus
Biological: Bivalent BNT162b2 (original/Omicron BA.4/BA.5) 10 microgram dose
Biological: Variant-adapted BNT162b2 (Omicron XBB.1.5) 10 microgram dose

This study is a Phase III, randomized, single-blind, placebo-controlled, multi-center study to be conducted in healthy infants and toddlers which wil...

Active, not recruiting
RSV Immunization
Biological: Diphtheria, tetanus, pertussis, Haemophilus influenzae type b and poliomyelitis vaccine
Biological: Streptococcus pneumoniae vaccine

This study is a phase III, randomized, observer-blind, placebo-controlled, multinational, multi-center study to be conducted in approximately 6300 ch...

Active, not recruiting
RSV Immunisation
Biological: Placebo
Biological: RSVt Vaccine

This study will evaluate the efficacy and safety of SPN-812 (viloxazine extended release) in children 4 to 5 years of age with ADHD.

Enrolling
Attention-Deficit/Hyperactivity Disorder
Drug: Placebo
Drug: 100mg SPN-812

Open label extension, long-term multicenter study of safety and efficacy of SPN-812 in pediatric ADHD patients

Active, not recruiting
Attention-Deficit/Hyperactivity Disorder
Drug: SPN-812

Performance of the LumiraDx SARS-CoV-2 Ag ULTRA assay will be assessed by comparison to a reference method

Active, not recruiting
COVID-19
Diagnostic Test: Nasopharyngeal swab
Diagnostic Test: Nasal Swab

The purpose of this study is to assess the safety, tolerability, and immunogenicity of the combined meningococcal groups A, B, C, W and Y (MenABCWY)...

Active, not recruiting
Meningitis, Meningococcal
Combination Product: MenABCWY vaccine
Combination Product: Placebo

This study is a Phase 3, randomized, modified double-blind study which aims to measure whether PCV21 vaccine (investigational pneumococcal conjugate...

Enrolling
Pneumococcal Immunization
Biological: Vaxelis vaccine
Biological: Varivax

This study is a Phase 3, randomized, modified double-blind study which aims to document the safety profile of the PCV21 vaccine (investigational pneu...

Enrolling
Pneumococcal Immunization
Biological: Varivax
Biological: M-M-R II vaccine

Trial sponsors

Sanofi logo
Sumitomo Pharma logo
Shire logo
Incyte logo
Pfizer logo
S
Supernus Pharmaceuticals logo
BioNTech logo
C
D

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems